In October 2005, Cerimon Pharmaceuticals, Inc. closed a Series A financing of $70 million with MPM Capital, Nomura Phase4 Ventures, OrbiMed Advisors and Stanford University.

If you are interested in learning more about Cerimon Pharmaceuticals, please contact James Welch, Chief Financial Officer at jwelch@cerimon.com.